About the Longevity & Human Enhancement Market Map
This market map tracks 102 startups across 8 categories in the Longevity & Human Enhancement landscape. Senolytics, epigenetic reprogramming, exoskeletons, nootropics, and implantable devices pushing the boundaries of human lifespan and performance. Curated by Hartmann Capital's venture research team, it provides a comprehensive view of the companies building in this space, from early-stage startups to growth-stage leaders.
Categories & Companies
Senolytics & Cellular Rejuvenation(13)
Unity Biotechnology (Public, $285M) · Rubedo Life Sciences (Series A, $40M) · Oisin Biotechnologies (Seed, $7M) · Cleara Biotech (Seed, $3M) · Cellarity (Series B, $243M) · Senolytic Therapeutics · Gordian Biotechnology (Series A, $60M) · Deciduous Therapeutics (Seed, $4M) · Cellvie (Seed, $5M) · Elevian (Series A, $21M) · Juvenescence (Series C, $200M) · Selphagy Therapeutics · Aeovian Pharmaceuticals (Series B, $105M)
Epigenetic Reprogramming & Gene Therapy(14)
Altos Labs (Series A, $3000M) · NewLimit (Series B, $175M) · Retro Biosciences (Series B, $1180M) · Turn Biotechnologies (Series A, $30M) · Life Biosciences (Series C, $207M) · Shift Bioscience (Seed, $18M) · Rejuvenate Bio (Series A, $15M) · Clock.bio (Seed, $5M) · Calico Life Sciences (Corporate, $2000M) · Cambrian Biopharma (Series A, $100M) · Fauna Bio (Seed, $4M) · Loyal (Series B, $85M) · LyGenesis (Series B, $25M) · Junevity (Seed, $10M)
Longevity Diagnostics & Biomarkers(12)
GlycanAge (Series A, $8M) · TruDiagnostic (Seed, $5M) · Elysium Health (Series B, $26M) · InsideTracker (Series B, $20M) · Generation Lab (Seed, $11M) · BioAge Labs (Public, $294M) · Insilico Medicine (Series D, $400M) · Function Health (Series A, $53M) · Superpower (Series A, $30M) · Viome (Series C, $175M) · Tally Health (Seed, $10M) · Human Longevity (Series E, $370M)
Nootropics & Cognitive Enhancement(13)
Thesis · Neurohacker Collective · Nootopia · Heights (Series A, $10M) · BrainCo (Series B, $30M) · Noowave · Onnit (Acquired, $28M) · TruBrain (Seed, $2M) · HVMN (Series A, $20M) · Nuvana · Neuro · Peak (Series B, $12M) · Natrium Health
Exoskeletons & Physical Augmentation(13)
Ekso Bionics (Public, $199M) · ReWalk Robotics (Public, $180M) · Wandercraft (Series C, $171M) · Cyberdyne (Public) · Sarcos (Palladyne AI) (Public, $100M) · German Bionic (Series B, $40M) · Verve Motion (Series B, $35M) · Roam Robotics (Series A, $18M) · Fourier Intelligence (Series D, $83M) · Myomo (Public, $25M) · Esper Bionics (Seed, $5M) · Cionic (Series A, $13M) · Bionik Laboratories (Public, $13M)
Implantable & Neural Devices(12)
Neuralink (Series F, $1200M) · Synchron (Series D, $270M) · Blackrock Neurotech (Growth, $200M) · Precision Neuroscience (Series C, $155M) · Paradromics (Series B, $108M) · Kernel (Series A, $54M) · Cognixion (Series A, $12M) · Science Corp (Series B, $168M) · Emotiv (Series A, $10M) · OpenBCI (Series A, $6M) · Cortec Neuro (Seed, $5M) · Motif Neurotech (Series A, $19M)
Longevity Clinics & Platforms(13)
AgelessRx (Pre-Seed, $1M) · Numan (Series B, $60M) · Midi Health (Series C, $100M) · Hevolution Foundation (Non-Profit) · Fountain Life (Series A, $30M) · Oura (Series D, $200M) · Ultrahuman (Series B, $55M) · Whoop (Series F, $400M) · Levels (Series A, $50M) · Thorne HealthTech (Public) · Longevity Copilot · Healthspan (Seed, $3M) · Wild Health (Series A, $15M)
Anti-Aging Supplements & Therapeutics(12)
ChromaDex (Public, $50M) · DoNotAge · ProHealth Longevity · Renue By Science · Tru Niagen (Subsidiary) · Life Extension · Alive By Nature · Longevity Labs · Novos Labs (Seed, $2M) · Timeline Nutrition (Series B, $68M) · Juvenon · Oxford Healthspan
Frequently Asked Questions
- What is the Longevity & Human Enhancement market map?
- The Longevity & Human Enhancement market map is a curated overview of 102 startups across 8 categories : Senolytics & Cellular Rejuvenation, Epigenetic Reprogramming & Gene Therapy, Longevity Diagnostics & Biomarkers, Nootropics & Cognitive Enhancement, Exoskeletons & Physical Augmentation, Implantable & Neural Devices, Longevity Clinics & Platforms, Anti-Aging Supplements & Therapeutics. Senolytics, epigenetic reprogramming, exoskeletons, nootropics, and implantable devices pushing the boundaries of human lifespan and performance. It is maintained by Hartmann Capital's venture research team.
- How many startups are tracked?
- This map currently tracks 102 startups across 8 categories: Senolytics & Cellular Rejuvenation (13 companies), Epigenetic Reprogramming & Gene Therapy (14 companies), Longevity Diagnostics & Biomarkers (12 companies), Nootropics & Cognitive Enhancement (13 companies), Exoskeletons & Physical Augmentation (13 companies), Implantable & Neural Devices (12 companies), Longevity Clinics & Platforms (13 companies), Anti-Aging Supplements & Therapeutics (12 companies).
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.
- How often is this map updated?
- The Longevity & Human Enhancement market map is updated on a rolling basis as new startups emerge, companies raise funding rounds, or the competitive landscape shifts.